VALEANT PHARMA INTL VRX (NYSE)

(ALISO VIEJO, Calif.)Valeant Pharmaceuticals Inc. said Wednesday it will buy privately held Coria Laboratories Ltd. for $95 million in a move to expand its dermatology business.READ MORE

(ALISO VIEJO, Calif.)Drug maker Valeant Pharmaceuticals Inc. said Friday it completed the sale of its Eastern and Western European businesses to Meda AB of Sweden. Valeant agreed to sell most of its op...READ MORE

(ALISO VIEJO, Calif.)Valeant Pharmaceuticals International said Thursday it will collaborate with GlaxoSmithKline PLC to develop and market epilepsy drug candidates in a deal that could bring Valeant p...READ MORE

Among the earnings stories for Monday, Aug. 11, from AP Financial News: ALISO VIEJO, Calif. (AP)--Valeant Pharmaceuticals International on Monday reported a second-quarter loss as ...READ MORE

(ALISO VIEJO, Calif.)Valeant Pharmaceuticals International on Monday reported a second-quarter loss as the company continued to pare its operations by eliminating businesses overseas.READ MORE

(ALISO VIEJO, Calif.)Valeant Pharmaceuticals International and Meda AB said Thursday they will collaborate to develop and market current and future products in Australia, Canada and Mexico, starting wi...READ MORE

(NEW YORK)The general counsel of specialty pharmaceutical company Valeant Pharmaceuticals International bought 2,054 shares of common stock, according to a Securities and Exchange Commission...READ MORE